Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    22149875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer
Condition: HER2-positive Locally Advanced or Metastatic Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Nab-paclitaxel;   Drug: Vinorelbine;   Drug: Eribulin;   Drug: Capecitabine;   Drug: Gemcitabine
2 Active, not recruiting
Has Results
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Pertuzumab;   Drug: Placebo;   Drug: Trastuzumab;   Drug: Docetaxel
3 Not yet recruiting Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Conditions: HER-2 Positive Breast Cancer;   Estrogen Receptor Positive Breast Cancer
Interventions: Drug: palbociclib;   Drug: trastuzumab;   Drug: pertuzumab;   Drug: letrozole;   Drug: Anastrozole;   Drug: Exemestane;   Drug: Fulvestrant
4 Completed Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Condition: Metastatic Breast Cancer
Intervention:

Study has passed its completion date and status has not been verified in more than two years.